GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Kontafarma China Holdings Ltd (HKSE:01312) » Definitions » Price-to-Free-Cash-Flow

Kontafarma China Holdings (HKSE:01312) Price-to-Free-Cash-Flow : 18.00 (As of Jun. 06, 2024)


View and export this data going back to 2012. Start your Free Trial

What is Kontafarma China Holdings Price-to-Free-Cash-Flow?

As of today (2024-06-06), Kontafarma China Holdings's share price is HK$0.036. Kontafarma China Holdings's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 was HK$0.00. Hence, Kontafarma China Holdings's Price-to-Free-Cash-Flow Ratio for today is 18.00.

The historical rank and industry rank for Kontafarma China Holdings's Price-to-Free-Cash-Flow or its related term are showing as below:

HKSE:01312' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 9.6   Med: 14.4   Max: 22.5
Current: 18

During the past 13 years, Kontafarma China Holdings's highest Price-to-Free-Cash-Flow Ratio was 22.50. The lowest was 9.60. And the median was 14.40.

HKSE:01312's Price-to-Free-Cash-Flow is ranked better than
59.73% of 524 companies
in the Drug Manufacturers industry
Industry Median: 22.885 vs HKSE:01312: 18.00

Kontafarma China Holdings's Free Cash Flow per Share for the six months ended in Dec. 2023 was HK$0.00. Its Free Cash Flow per Share for the trailing twelve months (TTM) ended in was HK$0.00.

During the past 3 years, the average Free Cash Flow per Share Growth Rate was -26.30% per year.

During the past 13 years, Kontafarma China Holdings's highest 3-Year average Free Cash Flow per Share Growth Rate was 49.30% per year. The lowest was -48.70% per year. And the median was -14.50% per year.


Kontafarma China Holdings Price-to-Free-Cash-Flow Historical Data

The historical data trend for Kontafarma China Holdings's Price-to-Free-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kontafarma China Holdings Price-to-Free-Cash-Flow Chart

Kontafarma China Holdings Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Free-Cash-Flow
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 17.40 - - 18.00

Kontafarma China Holdings Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Price-to-Free-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - 18.00

Competitive Comparison of Kontafarma China Holdings's Price-to-Free-Cash-Flow

For the Drug Manufacturers - Specialty & Generic subindustry, Kontafarma China Holdings's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Kontafarma China Holdings's Price-to-Free-Cash-Flow Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Kontafarma China Holdings's Price-to-Free-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Kontafarma China Holdings's Price-to-Free-Cash-Flow falls into.



Kontafarma China Holdings Price-to-Free-Cash-Flow Calculation

Kontafarma China Holdings's Price-to-Free-Cash-Flow ratio for today is calculated as

Price-to-Free-Cash-Flow Ratio=Share Price/ Free Cash Flow per Share (TTM)
=0.036/0.002
=18.00

Kontafarma China Holdings's Share Price of today is HK$0.036.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Kontafarma China Holdings's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 was HK$0.00.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

Price-to-Free-Cash-Flow Ratio=Market Cap/Free Cash Flow

Kontafarma China Holdings  (HKSE:01312) Price-to-Free-Cash-Flow Explanation

Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.

In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.


Be Aware

In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.


Kontafarma China Holdings Price-to-Free-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Kontafarma China Holdings's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Kontafarma China Holdings (HKSE:01312) Business Description

Traded in Other Exchanges
N/A
Address
30 Harbour Road, Room 12A 09-20, 12th Floor, Sun Hung Kai Centre, Wanchai, Hong Kong, HKG
Kontafarma China Holdings Ltd is principally engaged in the manufacture and sale of prescription drugs including chemical drugs and traditional Chinese medicine in the PRC, and the operation of fitness centers, provision of fitness and health consulting services, and the operation of franchises. The operating segments include pharmaceutical business and Fitness business. Majority of its revenue derives from pharmaceutical business segment.
Executives
Ning Bo Bao Shui Qu San Jin Guo Tou Gu Quan Tou Zi Ji Jin He Huo Qi Ye You Xian He Huo 2201 Interest of corporation controlled by you
Shan Xi Jiao Tong Kong Gu Ji Tuan You Xian Gong Si 2201 Interest of corporation controlled by you
Shan Xi Jian She Tou Zi Ji Tuan You Xian Gong Si 2201 Interest of corporation controlled by you
Shan Xi Sheng Ren Min Zheng Fu Guo You Zi Chan Jian Du Guan Li Wei Yuan Hui 2201 Interest of corporation controlled by you
Shan Xi Sheng Gao Su Gong Lu Ji Tuan You Xian Ze Ren Gong Si 2201 Interest of corporation controlled by you
Shan Xi Sheng Guo You Zi Ben Yun Ying You Xian Gong Si Qian Cheng Shan Xi Sheng Guo You Zi Ben Tou Z 2201 Interest of corporation controlled by you
China Health Management Investment Limited 2101 Beneficial owner
Waranty Assets Management (hk) Limited 2201 Interest of corporation controlled by you
Shen Zhen Shi Hua Rong Tai Zi Chan Guan Li You Xian Gong Si 2201 Interest of corporation controlled by you
Resuccess Investments Limited
Thtf Energy-saving Holdings Limited

Kontafarma China Holdings (HKSE:01312) Headlines

No Headlines